FDA panel backs Pfizer Covid-19 vaccine for 5- to 11-year-olds
Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks
Full Article
FDA panel backs Pfizer Covid-19 vaccine for 5- to 11-year-olds
FT.com
0 shares
2 views
You might like
Related news coverage
Texas & Florida Fight Back Against Pfizer & WEF
Rumble
“Contagious” brain disorders? “Deceptive” COVID shot marketing? “Nonsense” from the FDA? “Incentivized” killing in..
Advertisement
More coverage
WHO: ‘Vaccine Inequity . . . Demonstrates a Disregard for the World’s Poorest’
VOA News
The World Health Organization has written an open letter to the heads of state gathered in Rome for the G-20 meeting, urging them..
-
US children to soon start getting inoculated, FDA gives EUA to Pfizer COVID-19 vaccine
DNA
-
FDA gives EUA to Pfizer COVID-19 vaccine for children aged 5-11 in US
DNA
-
FDA Approves Pfizer's COVID Vaccine For Children 5-11 Years Old
Newsy
-
FDA Clears Pfizer COVID-19 Vaccine for Emergency Use in Children
VOA News